Lucerastat Uses, Dosage, Side Effects and more
Lucerastat is under investigation in clinical trial NCT03425539 (Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease).
| Attribute | Details |
|---|---|
| Trade Name | Lucerastat |
| Generic | Lucerastat |
| Lucerastat Other Names | Lucerastat |
| Type | |
| Formula | C10H21NO4 |
| Weight | Average: 219.281 Monoisotopic: 219.14705816 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
